C21ORF45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.587400E-01
Normal-vs-Stage2
9.726000E-01
Normal-vs-Stage3
2.722600E-01
Normal-vs-Stage4
2.753200E-01
Stage1-vs-Stage2
7.982000E-01
Stage1-vs-Stage3
2.888200E-01
Stage1-vs-Stage4
2.478600E-01
Stage2-vs-Stage3
2.973200E-01
Stage2-vs-Stage4
2.178600E-01
Stage3-vs-Stage4
8.474400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.368400E-01
Normal-vs-AfricanAmerican
5.323800E-01
Normal-vs-Asian
5.954200E-01
Caucasian-vs-AfricanAmerican
5.427800E-01
Caucasian-vs-Asian
5.572600E-01
AfricanAmerican-vs-Asian
8.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.711600E-01
Normal-vs-Female
6.673400E-01
Male-vs-Female
1.274000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.433600E-01
Normal-vs-Age(41-60Yrs)
8.728800E-01
Normal-vs-Age(61-80Yrs)
8.488600E-01
Normal-vs-Age(81-100Yrs)
6.345600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.545800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.091000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.098400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.830800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.620600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.367430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.706400E-01
Normal-vs-Daily Drinker
9.081400E-01
Normal-vs-Weekly Drinker
7.781600E-01
Normal-vs-Occasional Drinker
9.138200E-01
Normal-vs-Social Drinker
9.822600E-01
Non Drinker-vs-Daily Drinker
5.611600E-01
Non Drinker-vs-Weekly Drinker
4.739600E-01
Non Drinker-vs-Occasional Drinker
5.607000E-01
Non Drinker-vs-Social Drinker
7.579200E-01
Daily Drinker-vs-Weekly Drinker
8.037800E-01
Daily Drinker-vs-Occasional Drinker
9.469000E-01
Daily Drinker-vs-Social Drinker
7.970200E-01
Weekly Drinker-vs-Occasional Drinker
7.286400E-01
Weekly Drinker-vs-Social Drinker
6.067400E-01
Occasional Drinker-vs-Social Drinker
8.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.864600E-01
Normal-vs-Grade 2
5.885800E-01
Normal-vs-Grade 3
4.067600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.186200E-02
Grade 1-vs-Grade 3
2.416000E-03
Grade 1-vs-Grade 4
9.864600E-01
Grade 2-vs-Grade 3
1.475380E-01
Grade 2-vs-Grade 4
5.885800E-01
Grade 3-vs-Grade 4
4.067600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.769600E-01
Normal-vs-NonDiabetic
8.540000E-01
Diabetic-vs-NonDiabetic
9.443400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.940200E-01
Normal-vs-NoPancreatitis
8.929000E-01
Pancreatitis-vs-NoPancreatitis
7.461600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.240000E-01
Normal-vs-N1
9.114400E-01
N0-vs-N1
9.939600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.456200E-01
Normal-vs-TP53-NonMutant
9.834400E-01
TP53-Mutant-vs-TP53-NonMutant
2.452300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
